Literature DB >> 2982290

Ectopic ACTH syndrome. Diagnostic and therapeutic aspects.

R K Jex, J A van Heerden, P C Carpenter, C S Grant.   

Abstract

Twenty-five patients were identified with non-pituitary, nonadrenal ACTH-secreting tumors (bronchial carcinoid, bronchial small cell carcinoma, pancreatic islet cell carcinoma, medullary thyroid carcinoma, thymic carcinoids, metastatic adenocarcinoma, and pancreatic cystadenoma). Clinical features were weakness, hypertension, cushingoid appearance, peripheral edema, personality disorders, and hyperpigmentation. Biochemical features were a markedly increased urinary free cortisol level (all patients), hypokalemia (71 percent of patients), and an elevated ACTH level (72 percent of patients). Surgical therapy consisted of bilateral total adrenalectomy (56 percent of patients). Twelve percent underwent transsphenoidal hypophysectomy and 36 percent had excision of their tumor. No surgical therapy was undertaken in 28 percent. Bilateral total adrenalectomy in patients with a slow-growing malignancy or an unknown tumor secreting ACTH is beneficial in relieving symptoms and prolonging life. Excision of nonmalignant ACTH-producing tumors yields an excellent long-term prognosis.

Entities:  

Mesh:

Year:  1985        PMID: 2982290     DOI: 10.1016/s0002-9610(85)80085-4

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  14 in total

Review 1.  Endocrine paraneoplastic syndromes with special reference to the elderly.

Authors:  L Bollanti; G Riondino; F Strollo
Journal:  Endocrine       Date:  2001-03       Impact factor: 3.633

Review 2.  Primary aldosteronism.

Authors:  R D Gordon
Journal:  J Endocrinol Invest       Date:  1995 Jul-Aug       Impact factor: 4.256

3.  Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the University of Texas MD Anderson Cancer Center Experience.

Authors:  Shamim Ejaz; Rena Vassilopoulou-Sellin; Naifa L Busaidy; Mimi I Hu; Steven G Waguespack; Camilo Jimenez; Anita K Ying; Maria Cabanillas; Maher Abbara; Mouhammed Amir Habra
Journal:  Cancer       Date:  2011-03-15       Impact factor: 6.860

Review 4.  The ectopic ACTH syndrome.

Authors:  Krystallenia I Alexandraki; Ashley B Grossman
Journal:  Rev Endocr Metab Disord       Date:  2010-06       Impact factor: 6.514

5.  Cushing syndrome due to ectopic adrenocorticotropic hormone secretion.

Authors:  J P Aniszewski; W F Young; G B Thompson; C S Grant; J A van Heerden
Journal:  World J Surg       Date:  2001-07       Impact factor: 3.352

6.  Adrenocorticotropin-secreting carcinoid tumour identified and treated 12 years after presentation with Cushing's syndrome.

Authors:  B Vaidya; D Richardson; C J Hilton; P Kendall-Taylor
Journal:  Postgrad Med J       Date:  1997-11       Impact factor: 2.401

7.  Ectopic ACTH syndrome caused by pheochromocytoma: computed tomography-guided percutaneous ethanol injection as an alternative treatment.

Authors:  D L Danilovic; R A Brandão Neto; H D'Abronzo; M R Menezes; A M Lucon; B B Mendonca
Journal:  J Endocrinol Invest       Date:  2007-10       Impact factor: 4.256

8.  Utility of [(18)F] fluoro-2-deoxy-D: -glucose positron emission tomography in the localization of ectopic ACTH-secreting tumors.

Authors:  Aline Barbosa Moraes; Giselle F Taboada; Michel Pontes Carneiro; Leonardo Vieira Neto; Luiz Eduardo Armondi Wildemberg; Kalil Madi; Romeu Cortes Domingues; Mônica R Gadelha
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

9.  [68-year-old female patient with dyspnea and hypokalemic hypertension].

Authors:  K Müssig; C Maser-Gluth; M Hartmann; M Wehrmann; M Horger; L Kanz; H-U Häring; S A Wudy
Journal:  Internist (Berl)       Date:  2007-10       Impact factor: 0.743

10.  Neuroendocrine carcinoma of the ampulla of Vater causing ectopic adrenocorticotropic hormone-dependent Cushing's syndrome.

Authors:  Akihisa Kato; Kazuki Hayashi; Itaru Naitoh; Kyoji Seno; Yukiko Okada; Tesshin Ban; Hiromu Kondo; Yuji Nishi; Shuichiro Umemura; Yasuki Hori; Makoto Natsume; Takashi Joh
Journal:  Mol Clin Oncol       Date:  2016-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.